-

$undefined

N/A

(N/A)

REGULUS THERAPEUTICS INC NASDAQ:RGLS Regulus Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in La Jolla, CA.

Location: 10628 Science Center Dr Ste 225, California, 92121-1124, US | Website: regulusrx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-258.8K

Cash

87.31M

Avg Qtr Burn

-8.988M

Short % of Float

4.10%

Insider Ownership

2.21%

Institutional Own.

83.41%

Qtr Updated

09/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Farabursen (RGLS8429) Details Autosomal Dominant Polycystic Kidney Disease, Kidney disease	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.